Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent Deferred RevenueDividends payablesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current DebtNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Donegal (DGICA) Cash & Equivalents (2016 - 2026)

Donegal has reported Cash & Equivalents over the past 16 years, most recently at $26.8 million for Q4 2025.

  • Quarterly Cash & Equivalents fell 49.39% to $26.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $26.8 million through Dec 2025, down 49.39% year-over-year, with the annual reading at $26.8 million for FY2025, 49.39% down from the prior year.
  • Cash & Equivalents was $26.8 million for Q4 2025 at Donegal, down from $38.6 million in the prior quarter.
  • Over five years, Cash & Equivalents peaked at $102.4 million in Q1 2021 and troughed at $19.8 million in Q1 2024.
  • The 5-year median for Cash & Equivalents is $27.7 million (2024), against an average of $42.7 million.
  • Year-over-year, Cash & Equivalents tumbled 75.22% in 2022 and then surged 224.74% in 2025.
  • A 5-year view of Cash & Equivalents shows it stood at $57.7 million in 2021, then tumbled by 56.47% to $25.1 million in 2022, then fell by 5.3% to $23.8 million in 2023, then skyrocketed by 122.45% to $52.9 million in 2024, then plummeted by 49.39% to $26.8 million in 2025.
  • Per Business Quant, the three most recent readings for DGICA's Cash & Equivalents are $26.8 million (Q4 2025), $38.6 million (Q3 2025), and $57.4 million (Q2 2025).